In this study, we investigated the efficacy of CHIT1 inhibitor (OATD-01) in three different animal models of metabolic dysfunction-associated steatohepatitis (MASH). This evidence concerns the gene CHIT1 and metabolic dysfunction-associated steatohepatitis.